According to BlockBeats, on September 26, according to official news, AminoChain announced the completion of a $5 million seed round of financing. This round of financing was led by a16z and was also the first “DeSci” (i.e. “decentralized science”) project invested by a16z.

It is reported that AminoChain is building an L2 blockchain protocol that connects corporate medical institutions and building user-owned decentralized healthcare applications on the protocol. The first application built on AminoChain is a biospecimen market that allows researchers to query and license samples through a biospecimen library network. Patients can track their sample usage, learn from new insights generated from samples, and make money when selling these samples.

source